Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1666862

registered interest
date	24/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answers of 16 October 2023 to Questions 200120, 200121, 200122 and 200123 on Medial Treatments: Innovation, which criteria within the MedTech Strategy Programme governance structures will be used to assess the range of initiatives.
tabling member constituency	Dewsbury
tabling member printed	Mark Eastwood
uin	204055
answer	answer is ministerial correction date of answer 26/10/2023 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> answering member constituency Colchester answering member printed Will Quince question first answered 26/10/2023 08:59:38 answering member 4423 label Biography information for Will Quince
tabling member	4807 label Biography information for Mark Eastwood

1661403

registered interest
date	18/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medial Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to reform the NHS pathway for procurement of innovative medical technology; and when he expects the pathway to deliver timely access to medical technology.
tabling member constituency	Dewsbury
tabling member printed	Mark Eastwood
uin	200120
answer	answer is ministerial correction date of answer 16/10/2023 answer text <p>The Department’s inaugural Medical Technology (MedTech) Strategy was published on 3 February 2023, building on the broader Life Sciences Vision. We are committed to ensuring that the Department utilises innovative MedTech as implementation progresses.</p><p>The MedTech Strategy includes a range of initiatives aimed at streamlining the end-to-end innovation pathway, including procurement routes, to expedite patient access to MedTech and boost adoption within the National Health Service.</p><p>The Innovative Devices Access Pathway pilot was launched on 19 September 2023. This new pathway will provide multi-partner support for the rapid development of innovative technologies for adoption into the NHS to address unmet clinical needs. More information on the pilot is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap" target="_blank">https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap</a></p><p>The National Institute for Health and Care Excellence will undertake new Multi-Technology Evaluations of technologies in use and at a later stage in their lifecycle. These evaluations will enable comparisons between similar products and support the NHS to make better informed decisions on the right product for the right price.</p><p>The Department is working closely with NHS Supply Chain and NHS England to develop a consistent methodology for value-based procurement (VBP). VBP aims to shift procurement decisions away from an emphasis on reducing product costs to working with industry to consider technologies that represent a reduction in total costs within the patient pathway. Timeframes are still being determined.</p><p>The Department will consult on updating processes on applications to Part IX of the Drug Tariff to support the adoption of innovation in primary and community care.</p><p>The NHS Innovation Service is providing innovators with the resources, tools and support they need to increase the chances of getting their product or idea adopted by the NHS. More information is available at the following link:</p><p><a href="https://innovation.nhs.uk/" target="_blank">https://innovation.nhs.uk/</a></p><p>We plan to assess the impact of these initiatives through the MedTech Strategy Programme governance structures.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 200121 200122 200123 question first answered 16/10/2023 13:22:56 answering member 4423 label Biography information for Will Quince
tabling member	4807 label Biography information for Mark Eastwood

1661404

registered interest
date	18/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the adoption of innovative medical technologies by the NHS.
tabling member constituency	Dewsbury
tabling member printed	Mark Eastwood
uin	200121
answer	answer is ministerial correction date of answer 16/10/2023 answer text <p>The Department’s inaugural Medical Technology (MedTech) Strategy was published on 3 February 2023, building on the broader Life Sciences Vision. We are committed to ensuring that the Department utilises innovative MedTech as implementation progresses.</p><p>The MedTech Strategy includes a range of initiatives aimed at streamlining the end-to-end innovation pathway, including procurement routes, to expedite patient access to MedTech and boost adoption within the National Health Service.</p><p>The Innovative Devices Access Pathway pilot was launched on 19 September 2023. This new pathway will provide multi-partner support for the rapid development of innovative technologies for adoption into the NHS to address unmet clinical needs. More information on the pilot is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap" target="_blank">https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap</a></p><p>The National Institute for Health and Care Excellence will undertake new Multi-Technology Evaluations of technologies in use and at a later stage in their lifecycle. These evaluations will enable comparisons between similar products and support the NHS to make better informed decisions on the right product for the right price.</p><p>The Department is working closely with NHS Supply Chain and NHS England to develop a consistent methodology for value-based procurement (VBP). VBP aims to shift procurement decisions away from an emphasis on reducing product costs to working with industry to consider technologies that represent a reduction in total costs within the patient pathway. Timeframes are still being determined.</p><p>The Department will consult on updating processes on applications to Part IX of the Drug Tariff to support the adoption of innovation in primary and community care.</p><p>The NHS Innovation Service is providing innovators with the resources, tools and support they need to increase the chances of getting their product or idea adopted by the NHS. More information is available at the following link:</p><p><a href="https://innovation.nhs.uk/" target="_blank">https://innovation.nhs.uk/</a></p><p>We plan to assess the impact of these initiatives through the MedTech Strategy Programme governance structures.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 200120 200122 200123 question first answered 16/10/2023 13:22:56 answering member 4423 label Biography information for Will Quince
tabling member	4807 label Biography information for Mark Eastwood

1661405

registered interest
date	18/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase access to innovative medical technologies through the NHS.
tabling member constituency	Dewsbury
tabling member printed	Mark Eastwood
uin	200122
answer	answer is ministerial correction date of answer 16/10/2023 answer text <p>The Department’s inaugural Medical Technology (MedTech) Strategy was published on 3 February 2023, building on the broader Life Sciences Vision. We are committed to ensuring that the Department utilises innovative MedTech as implementation progresses.</p><p>The MedTech Strategy includes a range of initiatives aimed at streamlining the end-to-end innovation pathway, including procurement routes, to expedite patient access to MedTech and boost adoption within the National Health Service.</p><p>The Innovative Devices Access Pathway pilot was launched on 19 September 2023. This new pathway will provide multi-partner support for the rapid development of innovative technologies for adoption into the NHS to address unmet clinical needs. More information on the pilot is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap" target="_blank">https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap</a></p><p>The National Institute for Health and Care Excellence will undertake new Multi-Technology Evaluations of technologies in use and at a later stage in their lifecycle. These evaluations will enable comparisons between similar products and support the NHS to make better informed decisions on the right product for the right price.</p><p>The Department is working closely with NHS Supply Chain and NHS England to develop a consistent methodology for value-based procurement (VBP). VBP aims to shift procurement decisions away from an emphasis on reducing product costs to working with industry to consider technologies that represent a reduction in total costs within the patient pathway. Timeframes are still being determined.</p><p>The Department will consult on updating processes on applications to Part IX of the Drug Tariff to support the adoption of innovation in primary and community care.</p><p>The NHS Innovation Service is providing innovators with the resources, tools and support they need to increase the chances of getting their product or idea adopted by the NHS. More information is available at the following link:</p><p><a href="https://innovation.nhs.uk/" target="_blank">https://innovation.nhs.uk/</a></p><p>We plan to assess the impact of these initiatives through the MedTech Strategy Programme governance structures.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 200120 200121 200123 question first answered 16/10/2023 13:22:56 answering member 4423 label Biography information for Will Quince
tabling member	4807 label Biography information for Mark Eastwood

1661406

registered interest
date	18/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of innovative medical technologies on the (a) Life Sciences Vision and (b) MedTech Strategy.
tabling member constituency	Dewsbury
tabling member printed	Mark Eastwood
uin	200123
answer	answer is ministerial correction date of answer 16/10/2023 answer text <p>The Department’s inaugural Medical Technology (MedTech) Strategy was published on 3 February 2023, building on the broader Life Sciences Vision. We are committed to ensuring that the Department utilises innovative MedTech as implementation progresses.</p><p>The MedTech Strategy includes a range of initiatives aimed at streamlining the end-to-end innovation pathway, including procurement routes, to expedite patient access to MedTech and boost adoption within the National Health Service.</p><p>The Innovative Devices Access Pathway pilot was launched on 19 September 2023. This new pathway will provide multi-partner support for the rapid development of innovative technologies for adoption into the NHS to address unmet clinical needs. More information on the pilot is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap" target="_blank">https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap</a></p><p>The National Institute for Health and Care Excellence will undertake new Multi-Technology Evaluations of technologies in use and at a later stage in their lifecycle. These evaluations will enable comparisons between similar products and support the NHS to make better informed decisions on the right product for the right price.</p><p>The Department is working closely with NHS Supply Chain and NHS England to develop a consistent methodology for value-based procurement (VBP). VBP aims to shift procurement decisions away from an emphasis on reducing product costs to working with industry to consider technologies that represent a reduction in total costs within the patient pathway. Timeframes are still being determined.</p><p>The Department will consult on updating processes on applications to Part IX of the Drug Tariff to support the adoption of innovation in primary and community care.</p><p>The NHS Innovation Service is providing innovators with the resources, tools and support they need to increase the chances of getting their product or idea adopted by the NHS. More information is available at the following link:</p><p><a href="https://innovation.nhs.uk/" target="_blank">https://innovation.nhs.uk/</a></p><p>We plan to assess the impact of these initiatives through the MedTech Strategy Programme governance structures.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 200120 200121 200122 question first answered 16/10/2023 13:22:56 answering member 4423 label Biography information for Will Quince
tabling member	4807 label Biography information for Mark Eastwood